MINCHIOTTI, LORENZO
 Distribuzione geografica
Continente #
NA - Nord America 2.005
EU - Europa 1.606
AS - Asia 1.021
OC - Oceania 3
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.638
Nazione #
US - Stati Uniti d'America 1.997
CN - Cina 1.009
IE - Irlanda 476
UA - Ucraina 360
DE - Germania 231
FI - Finlandia 204
IT - Italia 84
GB - Regno Unito 83
SE - Svezia 82
FR - Francia 45
CZ - Repubblica Ceca 18
BE - Belgio 12
IN - India 8
CA - Canada 7
NL - Olanda 6
RU - Federazione Russa 5
IR - Iran 3
MU - Mauritius 2
NZ - Nuova Zelanda 2
AU - Australia 1
EU - Europa 1
PA - Panama 1
TR - Turchia 1
Totale 4.638
Città #
Dublin 475
Chandler 467
Jacksonville 439
Nanjing 308
Ashburn 113
Nanchang 104
Beijing 98
Princeton 92
Lawrence 89
Changsha 86
Hebei 83
Jiaxing 78
Shenyang 76
Wilmington 66
Medford 62
Ann Arbor 61
Boardman 56
Dearborn 51
Hangzhou 44
Tianjin 43
Helsinki 33
Shanghai 29
Woodbridge 28
Milan 26
Verona 23
Norwalk 21
Brno 18
Kunming 13
Munich 13
Brussels 12
Houston 11
Nürnberg 9
Fairfield 8
Paris 8
Falls Church 7
Los Angeles 7
Des Moines 6
New York 6
Jinan 5
Seattle 5
Auburn Hills 4
Lanzhou 4
Ningbo 4
Borås 3
Detroit 3
Guangzhou 3
Montréal 3
Taizhou 3
Toronto 3
Hefei 2
Las Vegas 2
Novokuznetsk 2
Pavia 2
Pune 2
Romainville 2
Saint-Fons 2
Tappahannock 2
Vigevano 2
Zhengzhou 2
Andover 1
Auckland 1
Bangalore 1
Blackpool 1
Changchun 1
Civitavecchia 1
Croom 1
Falkenstein 1
Gandhi Nagar 1
Groningen 1
Hastings 1
Irvine 1
Mumbai 1
North Bergen 1
Norwich 1
Orange 1
Panama City 1
Pozzuoli 1
San Jose 1
Shijiazhuang 1
Shiraz 1
Sondrio 1
Sydney 1
Washington 1
Winnipeg 1
Wuhan 1
Zanjan 1
Totale 3.256
Nome #
Analbuminemia in a Slovak Romany (gypsy) family: Case report and mutational analysis. 94
A two-base-pairs deletion in the albumin gene causes a new case of analbuminemia. 88
A novel splicing mutation causes an undescribed type of analbuminemia. 83
A novel frameshift deletion in the albumin gene causes analbuminemia in a young Turkish woman. 80
Structural analysis and fatty acid binding properties of two Croatian variants of human serum albumin. 79
Analysis of human serum albumin variants by mass spectrometric procedures. 78
Structural analysis, fatty acid and thyroxine binding properties of Vancouver and Naskapi variants of human serum albumin. 77
Structural caracterization of the oligosaccharide chains of human a1-microglobulin from urine and amniotic fluid. 72
Mutations and polymorphisms of the gene of the major human blood protein, serum albumin 70
A novel splicing mutation causes analbuminemia in a Portuguese boy. 70
The molecular defect of Albumin Tagliacozzo: 313Lys--->Asn. 68
A novel two bases deletion in the albumin gene causes analbuminaemia in a young turkish man. 68
Genetic variants showing apparent hot-spots in the human serum albumin gene. 66
MOLECULAR DEFECTS IN GENETIC VARIANTS OF HUMAN SERUM ALBUMIN 66
Molecular diagnosis of analbuminemia: A novel mutation identified in two amerindian and two Turkish families 65
Analbuminemia produced by a novel splicing mutation 65
An active site-tyrosine-containing heptapeptide from D-amino acid oxidase. 65
Analysis of human serum albumin variants by mass spectrometric procedures. 64
Analbuminemia in a Swedish male is caused by the Kayseri mutation (c228_229delAT) 62
Enzymatic properties of human hemalbumin. 61
STRUCTURAL CHARACTERIZATION OF TWO GENETIC VARIANTS OF HUMAN SERUM ALBUMIN 61
Analbuminemia Zonguldak: case report and mutational analysis. 61
The structural characterization and bilirubin-binding properties of albumin Herborn, a [Lys240-->Glu] albumin mutant. 61
Genetic variation in human serum albumin: a 313 Lys-->Asn mutation in albumin reading identified by PCR analysis. 61
A new proalbumin variant: albumin Jaffna (-1Arg--->Leu) 60
Novel nonsense mutation causes analbuminemia in a Moroccan family. 60
Analbuminemia in a Swiss family is caused by a C --> T transition at nucleotide 4446 of the albumin gene. 60
A structural study of pig liver glyceraldehyde-3-phosphate dehydrogenase. 60
MODIFIED HIGH_AFFINITY BINDING OF NICKEL; CALCIUM AND ZINC TO NATURAL MUTANTS OF HUMAN SERUM ALBUMIN AND PROALBUMIN 59
A novel nonsense mutation in the albumin gene (c.1275 C>A) causing analbuminemia in a Tunisian boy. 59
The amino acid substitution in albumin Roma: 321 Glu----Lys. 59
High-performance liquid chromatography of complex mixtures of cyanogen bromide-produced peptides from different proteins. 58
Structural characterization of a chain termination mutant of human serum albumin. 58
A donor splice mutation and a single-base deletion produce two carboxyl-terminal variants of human serum albumin. 58
Human alpha-1-Microglobulin is Covalently Bound to Kynurenine Derived Chromophores 57
D-amino acid oxidase primary structure: cyanogen bromide fragments and sequences of the cysteynyl peptides 57
A novel mutation in the albumin gene (c.1A>C) resulting in analbuminemia. 57
The molecular defect in a COOH-terminal-modified and shortened mutant of human serum albumin. 55
Structural characterization of four genetic variants of human serum albumin associated with alloalbuminemia in Italy. 55
Isolation, characterization and partial sequence of cyanogen bromide fragments and thiol peptides from pig kidney D-amino-acid oxidase. 55
Structural and biochemical characterization of a new type of lectin isolated from carp eggs. 54
Separation of cyanogen bromide fragments from normal and abnormal human serum albumin by reversed-phase high-performance liquid chromatography. 53
Albumin Benkovac (c.1175 A > G; p.Glu392Gly): a novel genetic variant of human serum albumin. 53
A novel frame-shift deletion causing analbuminaemia in an Italian paediatric patient. 52
A genetic variant of albumin (albumin Asola; Tyr140-->Cys) with no free -SH group but with an additional disulfide bridge. 52
A new bisalbuminemia: bisalbuminemia of Kenitra 52
TWO ALLOALBUMINS WITH IDENTICAL ELECTROPHORETIC MOBILITY ARE PRODUCED BYDIFFERENTLY CHARGED AMINO ACID SUBSTITUTIONS 51
Localization of the amino acid substitution site in a fast migrating variant of human serum albumin. 50
Hormone binding to natural mutants of human serum albumin. 50
MUTATIONS IN THE GENE OF HUMAN SERUM ALBUMIN: MOLECULAR AND FUNCTIONAL CONSEQUENCES AND THERAPEUTIC POSSIBILITIES 50
Identification of the amniotic fluid insulin-like growthfactor binding protein-1 phosphorylation sites andpropensity to proteolysis of the isoforms 49
Congenital analbuminemia caused by a novel aberrant splicing in the albumin gene 49
structural characterization of the subunits of spinach chloroplast glyceraldehyde-3-phoshate dehydrogenase (NADP). 49
Binding and relaxometric properties of heme complexes with cyanogen bromide fragments of human serum albumin 49
Molecular diagnosis of analbuminemia: a new case caused by a nonsense mutation in the albumin gene. 48
Structure and properties of the C-terminal domain of insulin-like growth factor-binding protein-1 isolated from human amniotic fluid. 48
Genetic variants of human serum albumin in Italy: point mutants and a carboxyl-terminal variant. 47
The molecular defect of albumin Castel di Sangro: 536 Lys----Glu. 47
PROTEIN AND DNA SEQUENCE ANALYSIS OF A PRIVATE GENETIC VARIANT: ALBUMIN ORTONOVO (Glu 505--Lys) 47
High-affinity binding of laurate to naturally occurring mutants of human serum albumin and proalbumin. 46
Effect of genetic variation on the fatty acid-binding properties of human serum albumin and proalbumin. 46
Structural characterization and fatty acid binding properties of two French genetic variants of human serum albumin. 45
Structural characterization of three genetic variants of human serum albumin modified in subdomains IIB and IIIA. 45
A nucleotide insertion and frameshift cause albumin Kenitra, an extended and O-glycosylated mutant of human serum albumin with two additional disulfide bridges. 45
A nucleotide deletion and frame-shift cause analbuminemia in a Turkish family. 44
Amino acid sequence around the pyridoxal 5'-phosphate binding sites of 6-phosphogluconate dehydrogenase. 44
MUTATIONS IN GENETIC VARIANTS OF HUMAN SERUM ALBUMIN FOUND IN ITALY 43
Isolation and characterization of a new form of the porcine pancreatic secretory trypsin inhibitor. Biochemical studies and high-resolution 1H-NMR 42
Structural characterization, stability and fatty acid-binding properties of two French genetic variants of human serum albumin. 42
Proceedings: Pyridoxal-phosphate-binding sites of 6-phosphogluconate dehydrogenase. 42
GENETIC VARIANTS OF HUMAN SERUM ALBUMIN: MOLECULAR AND FUNCTIONAL ASPECTS AND THERAPEUTIC POSSIBILITIES 41
Reactivity of D-amino acid oxidase with 1,2-cyclohexanedione: evidence for one arginine in the substrate-binding site. 40
Molecular Genetics of Analbuminemia 40
High-affinity binding of warfarin, salicylate and diazepam to natural mutants of human serum albumin modified in the C-terminal end. 39
A novel splicing mutation in the albumin gene (c.270+1G>T) causes analbuminaemia in a German infant 39
Purification and characterization of yeast thioredoxin reductase 38
Analbuminemia: three cases resulting from different point mutations in the albumin gene. 37
Molecular heterogeneity of ferredoxin-NADP+ reductase from spinach leaves. 36
Genetic variants of human serum albumin: molecular defects and biological stability. 35
Radioimmunoassay and chemical properties of glucose 6-phosphate dehydrogenase and of a specific NADP(H)-binding protein (FX) from human erythrocytes. 35
The primary structure of D-amino acid oxidase from pig kidney. II. Isolation and sequence of overlap peptides and the complete sequence. 35
Congenital analbuminaemia: molecular defects and biochemical and clinical aspects. 34
ANALBUMINEMIA: MOLECULAR ASPECTS AND CLINICAL CONSEQUENCES 31
The primary structure of D-amino acid oxidase from pig kidney. I. Isolation and sequence of the tryptic peptides. 29
Mutants and molecular dockings reveal that the primary L-thyroxine binding site in human serum albumin is not the one which can cause familial dysalbuminemic hyperthyroxinemia 27
Human serum albumin isoforms: genetic and molecular aspects and functional consequences. 27
Separation of fragments from human serum albumin and its charged variants by reversed-phase and cation-exchange high-performance liquid chromatography. 26
Clinical, genetic, and protein structural aspects of familial dysalbuminemic hyperthyroxinemia and hypertriiodothyroninemia 26
Congenital Analbuminemia in Unrelated Algerian and Turkish Families is Caused by the Same Molecular Defect in the Albumin Gene. 26
Totale 4.687
Categoria #
all - tutte 15.209
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.209


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20198 0 0 0 0 0 0 0 0 0 0 2 6
2019/20201.304 355 478 11 70 7 89 24 95 8 124 42 1
2020/2021587 76 62 12 67 2 79 4 93 12 88 80 12
2021/2022342 4 14 2 7 5 4 9 25 19 14 58 181
2022/20231.343 124 98 5 124 154 121 0 87 574 8 30 18
2023/2024366 39 91 5 27 37 117 3 27 2 16 2 0
Totale 4.687